Aurora Therapeutics has emerged from stealth with $16 million in funding from Menlo Ventures to expand the potential of gene ...

Machine learning models reveal that histone marks are predictive of gene expression across human cell types and highlight important nuances between natural control and the effects of CRISPR-Cas9-based ...

Friday, Aurora Therapeutics debuted with $16 million in seed capital from Menlo Ventures. Its goal: To develop the industry’s ...

CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today highlighted its strategic priorities and anticipated ...

New name reflects the Company’s strategic evolution focused on later-stage preclinical assets leveraging its most advanced, signature ...

Vegetarian and vegan are no longer niche concepts. It's estimated that up to 10 percent of the American population follows ...

A large genetic screen has revealed how stem cells transform into brain cells, exposing hundreds of genes that make this ...

Genetic treatments could be the key to unlocking some rare diseases. But bringing these medicines to patients involves ...

Gene-editing technologies show great promise for medical treatments and research, with the potential to cure thousands of ...

Aurora Therapeutics, cofounded by Nobel Prize–winning scientist Jennifer Doudna, plans to use gene editing and a new FDA ...

With 3,000 miles between them — and not much precedent behind the wheel — Stephen Dellaporta, in New Haven, CT, and Tom ...

If I were to locate the moment AI slop broke through into popular consciousness, I’d pick the video of rabbits bouncing on a ...